Collectively, our results demonstrate that the sensitivity of these tumor cells to the induction of the apoptotic pathway by TRAIL significantly depends on the levels of metabolites of the mevalonate pathway downstream of the activation of HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway [11]. This evidence concerns the gene HMGCR and neoplasm.